Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M I Wilde

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Drugs in R&D|January 21, 2000
New chemotherapeutic agents for influenza virus infections. Summary and tableM I Wilde, R Paterson
Pharmacoeconomics|April 7, 1998
Fluoxetine. A pharmacoeconomic review of its use in depressionM I Wilde, P Benfield
Drugs|November 1, 1996
Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applicationsM I Wilde, A Markham
Drugs|December 1, 1996
Tamsulosin. A review of its pharmacological properties and therapeutic potential in the management of symptomatic benign prostatic hyperplasiaM I Wilde, D McTavish
Drugs|October 27, 1997
Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitusM I Wilde, D McTavish
Drugs|January 9, 1998
Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopeniaM I Wilde, A Markham
Drugs|March 1, 1995
Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depressionM I Wilde, P Benfield
CNS Drugs|June 14, 2015
Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major DepressionR Davis, M I Wilde
Pharmacoeconomics|September 4, 1996
Sertraline. A pharmacoeconomic evaluation of its use in depressionR Davis, M I Wilde
Pharmacoeconomics|June 7, 1995
Paroxetine. A pharmacoeconomic evaluation of its use in depressionM I Wilde, R Whittington
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Drugs in R&D|January 21, 2000
New chemotherapeutic agents for influenza virus infections. Summary and tableM I Wilde, R Paterson
Pharmacoeconomics|April 7, 1998
Fluoxetine. A pharmacoeconomic review of its use in depressionM I Wilde, P Benfield
Drugs|November 1, 1996
Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applicationsM I Wilde, A Markham
Drugs|December 1, 1996
Tamsulosin. A review of its pharmacological properties and therapeutic potential in the management of symptomatic benign prostatic hyperplasiaM I Wilde, D McTavish
Drugs|October 27, 1997
Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitusM I Wilde, D McTavish
Drugs|January 9, 1998
Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopeniaM I Wilde, A Markham
Drugs|March 1, 1995
Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depressionM I Wilde, P Benfield
CNS Drugs|June 14, 2015
Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major DepressionR Davis, M I Wilde
Pharmacoeconomics|September 4, 1996
Sertraline. A pharmacoeconomic evaluation of its use in depressionR Davis, M I Wilde
Pharmacoeconomics|June 7, 1995
Paroxetine. A pharmacoeconomic evaluation of its use in depressionM I Wilde, R Whittington
Pageof 4